WELL Health Technologies (TSE:WELL) Downgraded to Neutral at CIBC

WELL Health Technologies (TSE:WELL - Get Free Report) was downgraded by research analysts at CIBC from an "outperform" rating to a "neutral" rating in a research report issued on Monday, BayStreet.CA reports. They currently have a C$4.75 target price on the stock, down from their previous target price of C$5.50. CIBC's price objective would indicate a potential upside of 26.33% from the stock's previous close.

Several other research firms also recently weighed in on WELL. Laurentian cut their price target on WELL Health Technologies from C$9.00 to C$6.50 and set a "buy" rating for the company in a research note on Thursday, November 16th. Desjardins dropped their price target on WELL Health Technologies from C$5.50 to C$5.25 and set a "hold" rating for the company in a research report on Wednesday, November 15th. TD Securities dropped their price target on WELL Health Technologies from C$8.50 to C$8.00 and set a "buy" rating for the company in a research report on Wednesday, November 15th. Finally, Stifel Nicolaus dropped their price target on WELL Health Technologies from C$12.00 to C$11.00 and set a "buy" rating for the company in a research report on Wednesday, November 15th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of C$7.47.

WELL Health Technologies Stock Performance

Shares of WELL Health Technologies stock traded down C$0.49 during mid-day trading on Monday, hitting C$3.76. 2,784,638 shares of the stock were exchanged, compared to its average volume of 826,222. WELL Health Technologies has a 12 month low of C$3.23 and a 12 month high of C$5.94. The company has a 50-day simple moving average of C$3.89 and a 200 day simple moving average of C$4.16. The company has a debt-to-equity ratio of 49.27, a quick ratio of 1.02 and a current ratio of 1.18. The company has a market capitalization of C$902.85 million, a P/E ratio of -188.00, a P/E/G ratio of -1.93 and a beta of 1.17.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers omni-channel healthcare services, including primary care and allied health clinic operations; gastrointestinal, and mental disorders; specialized care, including gastroenterology anesthesia services; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.